Related Experiment Video
Updated: Aug 18, 2026

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
Published on: August 4, 2022
MMF and eye disease
M Zierhut1, N Stübiger, K Siepmann
1Department of Ophthalmology I, University of Tuebingen, Tuebingen, Germany. manfred.zierhut@med.uni-tuebingen.de
Abstract:
Immunosuppressive treatment has shown to be effective in various ocular inflammatory disorders. Factors limiting their use are the individual response and the rate of side effects. This report summarizes our knowledge about the use of mycophenolate mofetil (MMF) in the treatment of ocular cicatricial pemphigoid (OCP), uveitis, atopic keratoconjunctivitis (AKC), prevention of graft rejection after penetrating keratoplasty (PK) and scleritis. Controlled studies have been performed for prevention of graft rejection after PK, showing MMF as effective in the prevention of graft rejection as cyclosporine A. In experimental uveitis, MMF has been demonstrated to be highly effective in prevention of retinal destruction. A number of studies have now shown that MMF also seems effective in uveitis. There are also studies with smaller patient groups which point out the effectiveness of MMF in OCP, AKC, and scleritis. In most of the studies, the spectrum of side effects was small, compared to other immunosuppressives.
Related Concept Videos
Photoreceptors and Visual Pathways
Accessory Structures of the Eye
Microbiome of the Eye
Glaucoma: Overview
Focusing of Light in the Eye

